Journey Medical Corp Stock Today
| DERM Stock | USD 5.12 0.07 1.39% |
Performance0 of 100
| Odds Of DistressLess than 12
|
Journey Medical is selling at 5.12 as of the 19th of September 2024; that is 1.39% increase since the beginning of the trading day. The stock's lowest day price was 5.06. Journey Medical has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Journey Medical Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of August 2024 and ending today, the 19th of September 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of November 2021 | Category Healthcare | Classification Health Care |
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. The company has 14.73 M outstanding shares of which 91.98 K shares are currently shorted by private and institutional investors with about 1.47 trading days to cover. More on Journey Medical Corp
Moving against Journey Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Journey Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Executive Chairman | Lindsay Rosenwald | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite Total, NASDAQ Health Care, NASDAQ Composite, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsJourney Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Journey Medical's financial leverage. It provides some insight into what part of Journey Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journey Medical Corp (DERM) is traded on NASDAQ Exchange in USA. It is located in 9237 East Via de Ventura Boulevard, Scottsdale, AZ, United States, 85258 and employs 41 people. Journey Medical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 104.67 M. Journey Medical Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 14.73 M outstanding shares of which 91.98 K shares are currently shorted by private and institutional investors with about 1.47 trading days to cover.
Journey Medical Corp currently holds about 38.14 M in cash with 5.24 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.17.
Check Journey Medical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Journey Medical is $104.67 Million. Journey Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Journey Ownership Details
Journey Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Integrated Wealth Concepts Llc | 2024-06-30 | 61.4 K | |
| Atria Investments Llc | 2024-06-30 | 55.3 K | |
| Blackrock Inc | 2024-06-30 | 51.9 K | |
| Gladstone Institutional Advisory Llc | 2024-06-30 | 33.5 K | |
| State Street Corp | 2024-06-30 | 25.6 K | |
| Brighton Jones Llc | 2024-06-30 | 23 K | |
| Perkins Capital Management Inc | 2024-06-30 | 22 K | |
| Cetera Investment Advisers | 2024-06-30 | 18.6 K | |
| Northern Trust Corp | 2024-06-30 | 17.7 K | |
| Vanguard Group Inc | 2024-06-30 | 310.2 K | |
| Cambridge Invest Research Advisors, Inc. | 2024-06-30 | 294.9 K |
Journey Medical Historical Income Statement
Journey Stock Against Markets
Journey Medical Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Robyn Hunter | Treasurer Sec | Profile | |
| Ernest Galvan | VP Strategy | Profile | |
| Joseph Benesch | Interim Controller | Profile | |
| Claude Maraoui | President, Founder | Profile | |
| Robert Nevin | Chief Officer | Profile |
Additional Information and Resources on Investing in Journey Stock
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.13 | Revenue Per Share 4.042 | Quarterly Revenue Growth (0.14) | Return On Assets 0.0197 | Return On Equity 0.1492 |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.